Net margin is calculated as Net Income divided by its Revenue. aXichem AB's Net Income for the
three
months ended in Mar. 2026 was €-0.27 Mil. aXichem AB's Revenue for the
three
months ended in Mar. 2026 was €0.36 Mil. Therefore, aXichem AB's net margin for the quarter that ended in Mar. 2026 was -75.49%.
The historical rank and industry rank for aXichem AB's Net Margin % or its related term are showing as below:
FRA:A6X'
s Net Margin % Range Over the Past 10 Years
Min: -3657.73 Med: -723.7 Max: -77.53
Current: -77.53
FRA:A6X's Net Margin % is ranked worse than 96.08% of 1581
companies
in the Chemicals industry
Industry Median: 3.89
vs FRA:A6X: -77.53
aXichem AB (FRA:A6X) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
aXichem AB Net Margin % Related Terms
aXichem AB Net Margin % Historical Data
* Premium members only.
The historical data trend for aXichem AB's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Specialty Chemicals subindustry, aXichem AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
aXichem AB Net Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, aXichem AB's Net Margin % distribution charts can be found below:
* The bar in red indicates where aXichem AB's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
aXichem AB (FRA:A6X) has a Net Margin % of -75.49% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on aXichem AB and its competitors. According to the industry distribution chart, aXichem AB ranks #1519 out of 1581 companies in the Chemicals industry, placing it in the top 96.1%.
Is aXichem AB's Net Margin % too high?
aXichem AB's current Net Margin % is -75.49%. Based on the distribution chart, aXichem AB ranks #1519 out of 1581 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, aXichem AB has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does aXichem AB's Net Margin % compare to LIN and SHW?
According to the Chemicals industry distribution chart, aXichem AB ranks #1519 out of 1581 companies for Net Margin %. This places aXichem AB in the lower half of its industry. The industry median Net Margin % is 3.89. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Chemicals company?
The median Net Margin % among Chemicals companies is 3.89, based on 1,581 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on aXichem AB and its competitors. For the Chemicals industry, the median Net Margin % is 3.89 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. aXichem AB's current Net Margin % is -75.49%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is aXichem AB stock overvalued right now?
aXichem AB (FRA:A6X) has a current Net Margin % of -75.49%. The stock's GF Value™ is €0.22, compared to a current price of €0.10 — trading 53.2% below its estimated fair value. The current Net Margin % is -75.49%. aXichem AB's overall GF Score™ is 50/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For aXichem AB (FRA:A6X), the current Net Margin % is -75.49% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is aXichem AB (FRA:A6X) Overvalued in 2026?
Based on GuruFocus' analysis, aXichem AB stock appears to be undervalued.
The current stock price of €0.10 is trading 53.2% below its estimated GF Value™ of €0.22.
Key valuation signals for FRA:A6X:
Net Margin %: -75.49%
GF Value™: €0.22 vs. price of €0.10 (53.2% below fair value)
No single metric tells the full story. See the FRA:A6X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
aXichem AB develops, patents, markets and sells natural analogue industrial chemicals, which are synthetically produced substances with similar and comparable properties to natural substances. The Company's business concept is to develop, patent, market and sell natural analogue industrial chemicals. Its commercial focus is on the proprietary patented product phenylcapsaicin, the Company's first product, which is marketed under the registered trademarks aXiphen as an additive in animal feed and aXivite as an ingredient in food supplements and as a bioenhancer. The Company's product portfolio comprises Phenylcapsaicin, aXiphen, aXiphen bio, and aXivite. The Company's focus is on establishing aXiphen as an additive in poultry feed and pig feed.
50GF Score
Get the complete analysis for FRA:A6X
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:A6X has been successfully added to your 
